ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Gross of the placeholder expense ratio and trading costs · not investor results
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1LLY | ELI LILLY & CO | Healthcare | $1.34T | 18.19% |
2AMD | ADVANCED MICRO DEVICES INC | Technology | $959.94B | 13.00% |
3MU | MICRON TECHNOLOGY INC | Technology | $903.37B | 12.24% |
4ABBV | ABBVIE INC | Healthcare | $520.47B | 7.05% |
5MRK | MERCK & CO INC | Healthcare | $362.27B | 4.91% |
6PANW | PALO ALTO NETWORKS INC | Technology | $263.94B | 3.58% |
7AMGN | AMGEN INC | Healthcare | $252.64B | 3.42% |
8DELL | DELL TECHNOLOGIES INC | Technology | $235.99B | 3.20% |
9CRWD | CROWDSTRIKE HOLDINGS INC | Technology | $235.37B | 3.19% |
10MPC | MARATHON PETROLEUM CORP | Energy | $112.41B | 1.52% |
11SNOW | SNOWFLAKE INC | Technology | $105.38B | 1.43% |
12VLO | VALERO ENERGY CORP | Energy | $104.57B | 1.42% |
13PSX | PHILLIPS 66 | Energy | $102.55B | 1.39% |
14FTNT | FORTINET INC | Technology | $95.17B | 1.29% |
15MRNA | MODERNA INC | Healthcare | $93.61B | 1.27% |
16DDOG | DATADOG INC | Technology | $66.60B | 0.90% |
17HPE | HEWLETT PACKARD ENTERPRISE CO | Technology | $66.59B | 0.90% |
18HUM | HUMANA INC | Healthcare | $53.29B | 0.72% |
19VEEV | VEEVA SYSTEMS INC | Healthcare | $48.96B | 0.66% |
20NTRA | NATERA INC | Healthcare | $46.83B | 0.63% |
21WDAY | WORKDAY INC | Technology | $45.94B | 0.62% |
22IQV | IQVIA HOLDINGS INC | Healthcare | $44.68B | 0.61% |
23ALAB | ASTERA LABS INC | Technology | $39.81B | 0.54% |
24TEAM | ATLASSIAN CORP | Technology | $38.35B | 0.52% |
25P | EVERPURE INC | Technology | $36.69B | 0.50% |
26NTAP | NETAPP INC | Technology | $36.55B | 0.50% |
27OKTA | OKTA INC | Technology | $31.91B | 0.43% |
28ILMN | ILLUMINA INC | Healthcare | $31.68B | 0.43% |
29ZS | ZSCALER INC | Technology | $31.51B | 0.43% |
30SN | SHARKNINJA INC | Consumer Cyclical | $31.02B | 0.42% |
31ROKU | ROKU INC | Communication Services | $23.93B | 0.32% |
32ARXS | ARXIS INC | Industrials | $23.17B | 0.31% |
33RBRK | RUBRIK INC | Technology | $22.88B | 0.31% |
34BBY | BEST BUY CO INC | Consumer Cyclical | $21.69B | 0.29% |
35SWKS | SKYWORKS SOLUTIONS INC | Technology | $21.14B | 0.29% |
36GH | GUARDANT HEALTH INC | Healthcare | $20.95B | 0.28% |
37IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | Basic Materials | $20.51B | 0.28% |
38PS | PERSHING SQUARE INC | Financial Services | $17.60B | 0.24% |
39RVTY | REVVITY INC | Healthcare | $17.53B | 0.24% |
40DINO | HF SINCLAIR CORP | Energy | $17.51B | 0.24% |
41NTNX | NUTANIX INC | Technology | $16.47B | 0.22% |
42CRL | CHARLES RIVER LABORATORIES INTERNATIONAL INC | Healthcare | $16.33B | 0.22% |
43W | WAYFAIR INC | Consumer Cyclical | $15.25B | 0.21% |
44DOCU | DOCUSIGN INC | Technology | $14.98B | 0.20% |
45ZBRA | ZEBRA TECHNOLOGIES CORP | Technology | $14.97B | 0.20% |
46MANH | MANHATTAN ASSOCIATES INC | Technology | $14.89B | 0.20% |
47GKOS | GLAUKOS CORP | Healthcare | $14.56B | 0.20% |
48SJM | J M SMUCKER CO | Consumer Defensive | $14.07B | 0.19% |
49FROG | JFROG LTD | Technology | $13.78B | 0.19% |
50DT | DYNATRACE INC | Technology | $12.88B | 0.17% |
51SAIL | SAILPOINT INC | Technology | $11.75B | 0.16% |
52HALO | HALOZYME THERAPEUTICS INC | Healthcare | $11.48B | 0.16% |
53PAYC | PAYCOM SOFTWARE INC | Technology | $11.21B | 0.15% |
54KYMR | KYMERA THERAPEUTICS INC | Healthcare | $10.86B | 0.15% |
55RGEN | REPLIGEN CORP | Healthcare | $10.64B | 0.14% |
56AVTR | AVANTOR INC | Basic Materials | $10.58B | 0.14% |
57LTH | LIFE TIME GROUP HOLDINGS INC | Consumer Cyclical | $10.23B | 0.14% |
58OSCR | OSCAR HEALTH INC | Healthcare | $9.92B | 0.13% |
59HNGE | HINGE HEALTH INC | Healthcare | $9.83B | 0.13% |
60TGTX | TG THERAPEUTICS INC | Healthcare | $9.76B | 0.13% |
61ZETA | ZETA GLOBAL HOLDINGS CORP | Technology | $9.52B | 0.13% |
62ESTC | ELASTIC NV | Technology | $9.35B | 0.13% |
63PCTY | PAYLOCITY HOLDING CORP | Technology | $9.30B | 0.13% |
64BRKR | BRUKER CORP | Healthcare | $9.21B | 0.12% |
65NTSK | NETSKOPE INC | Technology | $9.11B | 0.12% |
66PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | $8.77B | 0.12% |
67PBF | PBF ENERGY INC | Energy | $8.61B | 0.12% |
68VSXY | VICTORIA'S SECRET & CO | Consumer Cyclical | $8.35B | 0.11% |
69CORT | CORCEPT THERAPEUTICS INC | Healthcare | $8.07B | 0.11% |
70GTLB | GITLAB INC | Technology | $7.88B | 0.11% |
71TXG | 10X GENOMICS INC | Healthcare | $7.77B | 0.11% |
72S | SENTINELONE INC | Technology | $7.76B | 0.11% |
73KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | Healthcare | $7.56B | 0.10% |
74AMRX | AMNEAL PHARMACEUTICALS INC | Healthcare | $7.56B | 0.10% |
75CLF | CLEVELAND-CLIFFS INC | Basic Materials | $7.46B | 0.10% |
76ANDG | ANDERSEN GROUP INC | Consumer Cyclical | $7.39B | 0.10% |
77TWST | TWIST BIOSCIENCE CORP | Healthcare | $7.16B | 0.10% |
78ORKA | ORUKA THERAPEUTICS INC | Healthcare | $7.12B | 0.10% |
79XMTR | XOMETRY INC | Industrials | $6.96B | 0.09% |
80CAI | CARIS LIFE SCIENCES INC | Healthcare | $6.87B | 0.09% |
81KOD | KODIAK SCIENCES INC | Healthcare | $6.80B | 0.09% |
82CVLT | COMMVAULT SYSTEMS INC | Technology | $6.80B | 0.09% |
83ELF | ELF BEAUTY INC | Consumer Defensive | $6.71B | 0.09% |
84RNG | RINGCENTRAL INC | Technology | $6.41B | 0.09% |
85ANF | ABERCROMBIE & FITCH CO | Consumer Cyclical | $6.39B | 0.09% |
86SAIC | SCIENCE APPLICATIONS INTERNATIONAL CORP | Technology | $6.34B | 0.09% |
87LGND | LIGAND PHARMACEUTICALS INC | Healthcare | $6.33B | 0.09% |
88HRB | H&R BLOCK INC | Consumer Cyclical | $6.17B | 0.08% |
89QLYS | QUALYS INC | Technology | $6.04B | 0.08% |
90BOX | BOX INC | Technology | $5.99B | 0.08% |
91MANE | VERADERMICS INC | Healthcare | $5.71B | 0.08% |
92NIQ | NIQ GLOBAL INTELLIGENCE PLC | Communication Services | $5.67B | 0.08% |
93VRNS | VARONIS SYSTEMS INC | Technology | $5.66B | 0.08% |
94HAE | HAEMONETICS CORP | Healthcare | $5.59B | 0.08% |
95GRAL | GRAIL INC | Healthcare | $5.46B | 0.07% |
96INSW | INTERNATIONAL SEAWAYS INC | Energy | $5.35B | 0.07% |
97CAKE | CHEESECAKE FACTORY INC | Consumer Cyclical | $5.29B | 0.07% |
98BRZE | BRAZE INC | Technology | $5.29B | 0.07% |
99SEZL | SEZZLE INC | Financial Services | $5.23B | 0.07% |
100HTFL | HEARTFLOW INC | Healthcare | $5.21B | 0.07% |
101MMED | MINIMED GROUP INC | Healthcare | $5.03B | 0.07% |
102NSIT | INSIGHT ENTERPRISES INC | Technology | $4.98B | 0.07% |
103CNK | CINEMARK HOLDINGS INC | Communication Services | $4.80B | 0.07% |
104ADPT | ADAPTIVE BIOTECHNOLOGIES CORP | Healthcare | $4.77B | 0.06% |
105SYNA | SYNAPTICS INC | Technology | $4.69B | 0.06% |
106DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | $4.52B | 0.06% |
107ITGR | INTEGER HOLDINGS CORP | Healthcare | $4.30B | 0.06% |
108RHI | ROBERT HALF INC | Industrials | $4.30B | 0.06% |
109TENB | TENABLE HOLDINGS INC | Technology | $4.29B | 0.06% |
110GEO | GEO GROUP INC | Industrials | $4.26B | 0.06% |
111MGNI | MAGNITE INC | Communication Services | $4.21B | 0.06% |
112CDNA | CAREDX INC | Healthcare | $4.19B | 0.06% |
113DK | DELEK US HOLDINGS INC | Energy | $4.15B | 0.06% |
114CVI | CVR ENERGY INC | Energy | $4.13B | 0.06% |
115RLAY | RELAY THERAPEUTICS INC | Healthcare | $3.99B | 0.05% |
116VAC | MARRIOTT VACATIONS WORLDWIDE CORP | Consumer Cyclical | $3.96B | 0.05% |
117APPN | APPIAN CORP | Technology | $3.94B | 0.05% |
118PLSE | PULSE BIOSCIENCES INC | Healthcare | $3.84B | 0.05% |
119AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | $3.84B | 0.05% |
120ABCL | ABCELLERA BIOLOGICS INC | Healthcare | $3.80B | 0.05% |
121FA | FIRST ADVANTAGE CORP | Industrials | $3.67B | 0.05% |
122IOVA | IOVANCE BIOTHERAPEUTICS INC | Healthcare | $3.53B | 0.05% |
123INTA | INTAPP INC | Technology | $3.52B | 0.05% |
124ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | $3.48B | 0.05% |
125VIA | VIA TRANSPORTATION INC | Technology | $3.47B | 0.05% |
126VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | $3.46B | 0.05% |
127AVPT | AVEPOINT INC | Technology | $3.44B | 0.05% |
128AGYS | AGILYSYS INC | Technology | $3.43B | 0.05% |
129FRSH | FRESHWORKS INC | Technology | $3.32B | 0.05% |
130CLMT | CALUMET INC | Energy | $3.21B | 0.04% |
131BHC | BAUSCH HEALTH COMPANIES INC | Healthcare | $3.09B | 0.04% |
132XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | $3.04B | 0.04% |
133PENG | PENGUIN SOLUTIONS INC | Technology | $3.02B | 0.04% |
134XNCR | XENCOR INC | Healthcare | $2.86B | 0.04% |
135ATRC | ATRICURE INC | Healthcare | $2.85B | 0.04% |
136PRCH | PORCH GROUP INC | Technology | $2.83B | 0.04% |
137STGW | STAGWELL INC | Communication Services | $2.76B | 0.04% |
138CXW | CORECIVIC INC | Industrials | $2.72B | 0.04% |
139MBX | MBX BIOSCIENCES INC | Healthcare | $2.71B | 0.04% |
140BOBS | BOB'S DISCOUNT FURNITURE INC | Consumer Cyclical | $2.70B | 0.04% |
141AVAH | AVEANNA HEALTHCARE HOLDINGS INC | Healthcare | $2.67B | 0.04% |
142KSS | KOHLS CORP | Consumer Cyclical | $2.66B | 0.04% |
143PURR | HYPERLIQUID STRATEGIES INC | Financial Services | $2.44B | 0.03% |
144PEB | PEBBLEBROOK HOTEL TRUST | Real Estate | $2.41B | 0.03% |
145UFPT | UFP TECHNOLOGIES INC | Healthcare | $2.37B | 0.03% |
146SDGR | SCHRODINGER INC | Healthcare | $2.32B | 0.03% |
147PRGO | PERRIGO CO PLC | Healthcare | $2.25B | 0.03% |
148LIND | LINDBLAD EXPEDITIONS HOLDINGS INC | Consumer Cyclical | $2.24B | 0.03% |
149ASAN | ASANA INC | Technology | $2.21B | 0.03% |
150AMPL | AMPLITUDE INC | Technology | $2.21B | 0.03% |
151LIFE | ETHOS TECHNOLOGIES INC | Financial Services | $2.18B | 0.03% |
152NEO | NEOGENOMICS INC | Healthcare | $2.14B | 0.03% |
153BHVN | BIOHAVEN LTD | Healthcare | $2.13B | 0.03% |
154FIVN | FIVE9 INC | Technology | $2.12B | 0.03% |
155REPL | REPLIMUNE GROUP INC | Healthcare | $2.08B | 0.03% |
156IDT | IDT CORP | Communication Services | $2.06B | 0.03% |
157LPG | DORIAN LPG LTD | Energy | $2.05B | 0.03% |
158UTZ | UTZ BRANDS INC | Consumer Defensive | $2.05B | 0.03% |
159TRAX | FIRST TRACKS BIOTHERAPEUTICS INC | Healthcare | $2.05B | 0.03% |
160MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | Healthcare | $2.00B | 0.03% |
161SEPN | SEPTERNA INC | Healthcare | $1.99B | 0.03% |
162RLJ | RLJ LODGING TRUST | Real Estate | $1.97B | 0.03% |
163IOSP | INNOSPEC INC | Basic Materials | $1.95B | 0.03% |
164FTRE | FORTREA HOLDINGS INC | Healthcare | $1.94B | 0.03% |
165AZTA | AZENTA INC | Healthcare | $1.92B | 0.03% |
166ARHS | ARHAUS INC | Consumer Cyclical | $1.92B | 0.03% |
167VSTS | VESTIS CORP | Industrials | $1.88B | 0.03% |
168ZBIO | ZENAS BIOPHARMA INC | Healthcare | $1.87B | 0.03% |
169AGL | AGILON HEALTH INC | Healthcare | $1.85B | 0.03% |
170CERT | CERTARA INC | Healthcare | $1.82B | 0.02% |
171PRGS | PROGRESS SOFTWARE CORP | Technology | $1.78B | 0.02% |
172ULCC | FRONTIER GROUP HOLDINGS INC | Industrials | $1.77B | 0.02% |
173ETON | ETON PHARMACEUTICALS INC | Healthcare | $1.77B | 0.02% |
174CRCT | CRICUT INC | Technology | $1.77B | 0.02% |
175PSNL | PERSONALIS INC | Healthcare | $1.72B | 0.02% |
176NRIX | NURIX THERAPEUTICS INC | Healthcare | $1.70B | 0.02% |
177ATEX | ANTERIX INC | Communication Services | $1.63B | 0.02% |
178SLS | SELLAS LIFE SCIENCES GROUP INC | Healthcare | $1.62B | 0.02% |
179ABSI | ABSCI CORP | Healthcare | $1.57B | 0.02% |
180SG | SWEETGREEN INC | Consumer Cyclical | $1.48B | 0.02% |
181EFOR | EVERFORTH INC | Technology | $1.47B | 0.02% |
182PCRX | PACIRA BIOSCIENCES INC | Healthcare | $1.46B | 0.02% |
183CBRL | CRACKER BARREL OLD COUNTRY STORE INC | Consumer Cyclical | $1.45B | 0.02% |
184AMN | AMN HEALTHCARE SERVICES INC | Healthcare | $1.44B | 0.02% |
185CRSR | CORSAIR GAMING INC | Technology | $1.34B | 0.02% |
186URGN | UROGEN PHARMA LTD | Healthcare | $1.29B | 0.02% |
187GO | GROCERY OUTLET HOLDING CORP | Consumer Defensive | $1.27B | 0.02% |
188PD | PAGERDUTY INC | Technology | $1.24B | 0.02% |
189DRTS | ALPHA TAU MEDICAL LTD | Healthcare | $1.23B | 0.02% |
190RDVT | RED VIOLET INC | Technology | $1.22B | 0.02% |
191AMBQ | AMBIQ MICRO INC | Technology | $1.21B | 0.02% |
192BJRI | BJS RESTAURANTS INC | Consumer Cyclical | $1.20B | 0.02% |
193VOR | VOR BIOPHARMA INC | Healthcare | $1.19B | 0.02% |
194NUTX | NUTEX HEALTH INC | Healthcare | $1.18B | 0.02% |
195HZO | MARINEMAX INC | Consumer Cyclical | $1.17B | 0.02% |
196SIBN | SI-BONE INC | Healthcare | $1.09B | 0.01% |
197GDYN | GRID DYNAMICS HOLDINGS INC | Technology | $1.08B | 0.01% |
198VSTM | VERASTEM INC | Healthcare | $1.06B | 0.01% |
199HPK | HIGHPEAK ENERGY INC | Energy | $1.05B | 0.01% |
200CYRX | CRYOPORT INC | Industrials | $1.02B | 0.01% |
201EVER | EVERQUOTE INC | Communication Services | $989M | 0.01% |
202RPD | RAPID7 INC | Technology | $987M | 0.01% |
203REPX | RILEY EXPLORATION PERMIAN INC | Energy | $977M | 0.01% |
204FTK | FLOTEK INDUSTRIES INC | Energy | $937M | 0.01% |
205SXC | SUNCOKE ENERGY INC | Basic Materials | $913M | 0.01% |
206BBNX | BETA BIONICS INC | Healthcare | $898M | 0.01% |
207APPS | DIGITAL TURBINE INC | Technology | $890M | 0.01% |
208MTW | MANITOWOC CO INC | Industrials | $880M | 0.01% |
209MAX | MEDIAALPHA INC | Communication Services | $877M | 0.01% |
210PUBM | PUBMATIC INC | Technology | $872M | 0.01% |
211EVC | ENTRAVISION COMMUNICATIONS CORP | Communication Services | $870M | 0.01% |
212BLMN | BLOOMIN' BRANDS INC | Consumer Cyclical | $868M | 0.01% |
213HSTM | HEALTHSTREAM INC | Healthcare | $867M | 0.01% |
214RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | $860M | 0.01% |
215KIDS | ORTHOPEDIATRICS CORP | Healthcare | $851M | 0.01% |
216MCS | MARCUS CORP | Communication Services | $846M | 0.01% |
217WEST | WESTROCK COFFEE CO | Consumer Defensive | $841M | 0.01% |
218OSPN | ONESPAN INC | Technology | $828M | 0.01% |
219CLMB | CLIMB GLOBAL SOLUTIONS INC | Technology | $804M | 0.01% |
220INN | SUMMIT HOTEL PROPERTIES INC | Real Estate | $780M | 0.01% |
221VREX | VAREX IMAGING CORP | Healthcare | $769M | 0.01% |
222YEXT | YEXT INC | Technology | $757M | 0.01% |
223CLDT | CHATHAM LODGING TRUST | Real Estate | $755M | 0.01% |
224IBEX | IBEX LTD | Technology | $732M | 0.01% |
225KRT | KARAT PACKAGING INC | Consumer Cyclical | $707M | 0.01% |
226NVCT | NUVECTIS PHARMA INC | Healthcare | $696M | 0.01% |
227QUIT | ACHIEVE LIFE SCIENCES INC | Healthcare | $692M | 0.01% |
228PKOH | PARK OHIO HOLDINGS CORP | Industrials | $679M | 0.01% |
229SPT | SPROUT SOCIAL INC | Technology | $678M | 0.01% |
230QMCO | QUANTUM CORP | Technology | $658M | 0.01% |
231SGHT | SIGHT SCIENCES INC | Healthcare | $611M | 0.01% |
232WEYS | WEYCO GROUP INC | Consumer Cyclical | $578M | 0.01% |
233BLZE | BACKBLAZE INC | Technology | $556M | 0.01% |
234CIX | COMPX INTERNATIONAL INC | Industrials | $546M | 0.01% |
235OPRT | OPORTUN FINANCIAL CORP | Financial Services | $542M | 0.01% |
236PAYS | PAYSIGN INC | Technology | $540M | 0.01% |
237TKNO | ALPHA TEKNOVA INC | Healthcare | $522M | 0.01% |
238BBCP | CONCRETE PUMPING HOLDINGS INC | Industrials | $518M | 0.01% |
239RCEL | AVITA MEDICAL INC | Healthcare | $509M | 0.01% |
240DMAC | DIAMEDICA THERAPEUTICS INC | Healthcare | $503M | 0.01% |
241BXC | BLUELINX HOLDINGS INC | Industrials | $494M | 0.01% |
242ACCO | ACCO BRANDS CORP | Industrials | $494M | 0.01% |
243OBIO | ORCHESTRA BIOMED HOLDINGS INC | Healthcare | $484M | 0.01% |
244KELYA | KELLY SERVICES INC | Industrials | $481M | 0.01% |
245WNC | WABASH NATIONAL CORP | Industrials | $477M | 0.01% |
246EOLS | EVOLUS INC | Healthcare | $475M | 0.01% |
247CARL | CARLSMED INC | Healthcare | $474M | 0.01% |
248MEI | METHODE ELECTRONICS INC | Technology | $443M | 0.01% |
249SI | SHOULDER INNOVATIONS INC | Healthcare | $441M | 0.01% |
250PBYI | PUMA BIOTECHNOLOGY INC | Healthcare | $418M | 0.01% |
251JAKK | JAKKS PACIFIC INC | Consumer Cyclical | $416M | 0.01% |
252HBB | HAMILTON BEACH BRANDS HOLDING CO | Consumer Cyclical | $410M | 0.01% |
253MASS | 908 DEVICES INC | Healthcare | $407M | 0.01% |
254FNKO | FUNKO INC | Consumer Cyclical | $389M | 0.01% |
255FENC | FENNEC PHARMACEUTICALS INC | Healthcare | $382M | 0.01% |
256TBI | TRUEBLUE INC | Industrials | $377M | 0.01% |
257TWIN | TWIN DISC INC | Industrials | $358M | 0.00% |
258TMCI | TREACE MEDICAL CONCEPTS INC | Healthcare | $350M | 0.00% |
259PEPG | PEPGEN INC | Healthcare | $349M | 0.00% |
260JILL | JJILL INC | Consumer Cyclical | $333M | 0.00% |
261CHPT | CHARGEPOINT HOLDINGS INC | Consumer Cyclical | $324M | 0.00% |
262AGEN | AGENUS INC | Healthcare | $311M | 0.00% |
263TTRX | TURN THERAPEUTICS INC | Healthcare | $310M | 0.00% |
264SMTI | SANARA MEDTECH INC | Healthcare | $299M | 0.00% |
265EAF | GRAFTECH INTERNATIONAL LTD | Industrials | $298M | 0.00% |
266TBCH | TURTLE BEACH CORP | Technology | $296M | 0.00% |
267RFAI | RF ACQUISITION CORP II | Financial Services | $287M | 0.00% |
268ACU | ACME UNITED CORP | Consumer Defensive | $279M | 0.00% |
269FRD | FRIEDMAN INDUSTRIES INC | Basic Materials | $275M | 0.00% |
270QTTB | Q32 BIO INC | Healthcare | $264M | 0.00% |
271ULBI | ULTRALIFE CORP | Industrials | $263M | 0.00% |
272AOUT | AMERICAN OUTDOOR BRANDS INC | Consumer Cyclical | $240M | 0.00% |
273VRA | VERA BRADLEY INC | Consumer Cyclical | $217M | 0.00% |
274AMWL | AMERICAN WELL CORP | Healthcare | $207M | 0.00% |
275FIRY | FIRY INC | Communication Services | $200M | 0.00% |
276CLAR | CLARUS CORP | Consumer Cyclical | $198M | 0.00% |
277BSET | BASSETT FURNITURE INDUSTRIES INC | Consumer Cyclical | $187M | 0.00% |
278ACOG | ALPHA COGNITION INC | Healthcare | $186M | 0.00% |
279ANIK | ANIKA THERAPEUTICS INC | Healthcare | $185M | 0.00% |
280AEYE | AUDIOEYE INC | Technology | $181M | 0.00% |
281VNCE | VINCE HOLDING CORP | Consumer Cyclical | $167M | 0.00% |
282RRGB | RED ROBIN GOURMET BURGERS INC | Consumer Cyclical | $167M | 0.00% |
283FORR | FORRESTER RESEARCH INC | Industrials | $166M | 0.00% |
284BOOM | DMC GLOBAL INC | Energy | $164M | 0.00% |
285CUE | CUE BIOPHARMA INC | Healthcare | $127M | 0.00% |
286WW | WW INTERNATIONAL INC | Consumer Cyclical | $123M | 0.00% |
287OPHC | OPTIMUMBANK HOLDINGS INC | Financial Services | $113M | 0.00% |
288BDSX | BIODESIX INC | Healthcare | $109M | 0.00% |
289TISI | TEAM INC | Industrials | $107M | 0.00% |
290BDL | FLANIGANS ENTERPRISES INC | Consumer Cyclical | $107M | 0.00% |
291CPIX | CUMBERLAND PHARMACEUTICALS INC | Healthcare | $99M | 0.00% |
292JRSH | JERASH HOLDINGS (US) INC | Consumer Cyclical | $93M | 0.00% |
293RLYB | RALLYBIO CORP | Healthcare | $84M | 0.00% |
294ATRA | ATARA BIOTHERAPEUTICS INC | Healthcare | $81M | 0.00% |
295NTRB | NUTRIBAND INC | Healthcare | $73M | 0.00% |
296NTWK | NETSOL TECHNOLOGIES INC | Technology | $63M | 0.00% |
297OESX | ORION ENERGY SYSTEMS INC | Industrials | $54M | 0.00% |
298ELOX | ELOXX PHARMACEUTICALS INC | Healthcare | $52M | 0.00% |
Full long-leg book as of November 2026 · cap-weighted · total market cap $7.38T. Hypothetical model holdings — not a registered fund’s portfolio.
Size × value map of the long-leg book
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
With respect to 75% of total assets, no more than 5% may be invested in the securities of any one issuer.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20261113T032607 rows=2198308 asof=202611 issuers=20261113T063725 rates=20261113T063725
Measured on the 2026-11 formation date across 298 holdings (cap-weighted). A different formation date can produce different verdicts.
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 335 monthly observations · about 3.4 in the 99% tail · paired percentile bootstrap over months
The estimators agree, which is mild evidence the number isn’t an artefact of one method.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Did the edge survive the paper coming out?
There is no “before” to compare against — the predictor was already public when our data begins, so every month shown is out-of-sample relative to the original study.
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | -1.1% | -44.1% |
| 3 yearsp.a. | 15.2% | -20.9% |
| 5 yearsp.a. | 9.3% | -13.0% |
| 10 yearsp.a. | 17.3% | 1.4% |
| Since inceptionp.a. | 12.8% | 5.3% |
| Year | Long leg | Long-short |
|---|---|---|
| 202611 mo | -0.6% | -43.2% |
| 2025 | -5.8% | -34.7% |
| 2024 | 54.4% | 44.9% |
| 2023 | 36.5% | -16.0% |
| 2022 | -17.0% | 17.5% |
| 2021 | 14.6% | 2.8% |
| 2020 | 68.0% | 58.9% |
| 2019 | 19.0% | -13.0% |
| 2018 | -0.7% | 18.0% |
| 2017 | 31.4% | 30.5% |
| 2016 | 9.4% | -5.0% |
| 2015 | 4.0% | 11.4% |
| 2014 | 12.1% | 11.4% |
| 2013 | 48.5% | 13.5% |
| 2012 | 13.4% | -16.7% |
| 2011 | -2.5% | 6.1% |
| 2010 | 37.4% | 23.7% |
| 2009 | 5.7% | -42.0% |
| 2008 | -35.4% | 39.3% |
| 2007 | 30.2% | 40.2% |
| 2006 | 6.8% | -8.8% |
| 2005 | 19.5% | 6.5% |
| 2004 | 9.0% | -6.6% |
| 2003 | 57.0% | 25.2% |
| 2002 | -29.0% | 3.2% |
| 2001 | -17.8% | 4.6% |
| 2000 | -9.7% | 17.0% |
| 1999 | 100.9% | 54.5% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through November 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
The Foundry 6-Month Momentum Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a 6-Month Momentum signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,140-name universe at November 2026. Rows: Large ≥ $5.3B, Small < $832M. Columns: Value ≥ 0.62, Growth < 0.33 B/M. The dot marks the capital-weighted centroid of the book — 98% toward Large, 83% toward Growth. +2% unclassified (37 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → November 2026; the right-hand end is the same value as the box’s dot. 298 names now. Hypothetical holdings — descriptive, not P&L.